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Abstract
Objectives
Higher or lower blood pressure may relate to cognitive impairment, while the relationship
between blood pressure and cognitive impairment among the elderly is not well-studied. The
study objective was to determine whether blood pressure is associated with cognitive
impairment in the elderly, and, if so, to accurately describe the association.
Design
Cross-sectional data from the sixth wave of the Chinese Longitudinal Healthy Longevity
Survey (CLHLS) conducted in 2011
Setting
Community-based setting in longevity areas in China
Participants
7,144 Chinese elderly aged 65 years and older were included in the sample
Measures
Systolic blood pressures (SBP) and diastolic blood pressures (DBP) were measured, pulse
pressure (PP) was calculated as (SBP)-(DBP) and mean arterial pressures (MAP) was
calculated as 1/3(SBP) + 2/3(DBP). Cognitive function was assessed via a validated MiniMental State Examination (MMSE).
Results
Based on the results of generalized additive models (GAMs), U-shaped associations were
identified between cognitive impairment and SBP, DBP, PP and MAP. The cut-points at
which risk for cognitive impairment (MMSE<24) was minimized were determined by
quadratic models as 141 mmHg, 85 mmHg, 62 mmHg and 103 mmHg, respectively. In the
logistic models, U-shaped associations remained for SBP, DBP, and MAP but not PP. Below
the identified cut-points, each 1mmHg decrease in blood pressure corresponded to 0.7%,
1.1%, and 1.1% greater risk in the risk of cognitive impairment, respectively. Above the cutpoints, each 1mmHg increase in blood pressure corresponded to 1.2%, 1.8%, and 2.1%
greater risk of cognitive impairment for SBP, DBP and MAP, respectively.
Conclusion
A U-shaped association between blood pressure and cognitive function in an elderly Chinese
population was found. Recognition of these instances is important identifying the high-risk
population for cognitive impairment and to individualize blood pressure management for
cognitive impairment prevention.
Keywords: blood pressure, hypertension, hypotension, cognitive impairment, curvilinear
association, elderly

Introduction
Hypertension and hypotension are important risk factors for vascular diseases, which may
lead to cognitive impairment due to stroke or chronic cerebral hypoperfusion in the elderly
[1]. This suggests that hypertension and hypotension may both be associated with cognitive
impairment, a common neurological disorder in the elderly.
In recent years, the link between blood pressure, including systolic blood pressures (SBP) and
diastolic blood pressures (DBP), to cognitive function has attracted much attention, but the
role of blood pressure in cognitive impairment is still unclear [2–14]. Several studies reported
a linear association between elevated blood pressure and increased risk of cognitive
impairment or dementia [2, 3], and low blood pressure was related to higher risk of dementia
in the elderly [4, 5]. Additionally, antihypertensive medicines have a valuable role in the
prevention of dementia or cognitive impairment [6, 7], while some studies failed to confirm
this association [8, 9].
One proposed explanation for inconsistencies among these studies is that the relationship
between blood pressure and cognitive function is nonlinear. Several investigators have
demonstrated a U-shaped relationship [10–14] or a J-shaped association between cognitive
function and blood pressure [4]. Most related researches use linear model including
multivariate regression model [12,15], hierarchical linear model [14,16], mixed-effects
regression analyses[11] to examine the possible relations. Few studies use splines to
determine presence and type of the curvilinear relationships [17]. None of the curvilinear
associations were demonstrated using generalized additive models (GAMs) and quadratic
models, whose strengths include the ability to determine the natural shape of the relationship,
sensitivity to detect non-linear relationships and identifying the optimal cut-points between
dependent and predictor variable(s).
Combined measures such as pulse pressure (PP) or mean arterial pressure (MAP) may be a
salient blood pressure index in the elderly[18] as SBP continuously increases and DBP
continuously decreases after age 60[19]. Notably, PP and cognitive function have not been
extensively studied, with positive associations with cognitive impairment being reported in
some [20–23] but not all [24] studies. Some studies suggest that MAP may be a more
accurate predictor than other blood pressure indices [25, 26].
It is important to clarify whether blood pressure is associated with cognitive impairment in
the elderly, and, if so, to accurately describe the association. In the present study, we
investigated the relationship between blood pressure (as measured by SBP, DBP, PP and
MAP) and cognitive impairment among Chinese elderly, and the possibility of a linear or
curvilinear relationship using GAMs and quadratic models.

Methods
Study population
A sample of 7144 elderly aged 65 years and older was included in the sixth wave of the
Chinese Longitudinal Healthy Longevity Survey (CLHLS) conducted in 2011. The details of
the CLHLS and sample design have been described elsewhere[27,28]. Informed consent was
obtained from all participants and/or their relatives, and the study was approved by the Ethics
Committee of Peking University.

Assessment of cognitive function
Cognitive function was assessed by the Mini-Mental State Examination (MMSE) [29], which
has been widely applied in epidemiological studies. Five domains of cognitive function were
included, namely orientation, registration, attention, memory, language and visual
construction skills [30]. The scores ranged from 0 to 30 points, and cognitive impairment was
identified if the MMSE score was less than 24 [31].
Assessment of blood pressure
After having rested for 5 minutes under supervision of trained research assistants, arterial
blood pressure was measured with a mercury sphygmomanometer on the right arm at heart
level of the seated subject. In our analysis, the mean value of two blood pressure
measurements was calculated and used for further analyses. PP was calculated as (SBP)(DBP) and MAP was calculated as 1/3(SBP) + 2/3(DBP). Hypertension was defined as
systolic blood pressure ≥140mm Hg and/or diastolic blood pressure ≥90mm Hg.
Assessment of covariates
Covariates were collected by a structured questionnaire, one part is sociodemographic
characteristics including age, sex, educational background and residence; the other part is
health characteristics including physical activity, measured waist circumference, and selfreported diabetes mellitus, cardiovascular diseases and stroke and other cerebrovascular
diseases. Age and education were two of the most important confounders in the analysis of
association between cognitive impairment and blood pressure, and were modeled as
continuous variables in years. Residence was categorized as urban or rural. Physical activity
was classified into “yes” or “no” by the question “Do you often participate in physical
activities, including walking, playing ball, running, and Qigong?”. Non-stretchable tape was
used to measure waist circumference at a level between the lowest rib and iliac crest. Central
obesity was identified if the participant’s waist circumference was ≥85cm in men or ≥80cm
in women.
Statistical analyses
Generalized additive models were performed to explore the linear or curvilinear association
between SBP, DBP, PP, MAP and odds of having cognitive impairment. GAMs establish a
relationship between the mean of a dependent variable and a smoothed (non-parametric)
function of the predictor variable(s) via a link function. As GAM analysis suggested Ushaped associations between SBP, DBP, PP, MAP and risk of cognitive impairment on the
basis of smoothed curve (Figure 1), quadratic regression was performed predicting risk of
cognitive impairment: Pr(Cognitive impairment|Blood pressure) = {1+exp[-( + 1(Blood
pressure)+ 2(Blood pressure)2]}−1, with models parameters , 1 and 2 estimated using
maximum likelihood methods. If 1 and 2 are both non-zero and statistically significant, then
the estimated level of blood pressure at which risk of cognitive impairment is minimized is ( 1/2 2). These values are used as cut-points of blood pressure for further analysis. For SBP,
DBP, PP and MAP, the 1 were estimated as −0.07908, −0.10114, −0.03585 and −0.13279
respectively, and the 2 were estimated as 0.00028, 0.00059, 0.00029 and 0.00064
respectively; all p values were less than 0.01. The blood pressure values associated with
lowest risk were identified as 141 mm Hg, 85 mm Hg, 62 mm Hg and 103 mm Hg for SBP,
DBP, PP and MAP, respectively. For each blood pressure measure, subjects were divided
into 4 groups, first based on whether they were above or below the cut-point for that measure,
and within these 2 groups whether they were above or below the mean value of that measure.
Thus, subjects were first stratified into two groups by cut-points of each blood pressure index

(values noted above); subjects in the low group were then divided into two sub-groups
(denoted low and medium-low) using medians of each index (127mm Hg, 77 mm Hg, 49 mm
Hg, 93 mm Hg for SBP, DBP, PP and MAP, respectively) and subjects in the high group
were divided into two sub-groups (denoted high and medium-high) using the medians of each
index (155mm Hg, 90 mm Hg, 73 mm Hg, 110 mm Hg for SBP, DBP, PP and MAP
respectively).
Then logistic regression models were performed to assess the risk of cognitive impairment
with SBP, DBP, PP and MAP as continuous or binary predictor variables below and above
the cut-points. In a basic model, we adjusted for demographic variables including age,
gender, years of education, and residence, and further adjusted for physical activity, central
obesity, diabetes mellitus, cardiovascular diseases, stroke and cerebrovascular diseases in the
final model. Odds ratios (ORs) with 95% confidence intervals (CIs) in logistic regression
models were presented. SAS 9.2 (SAS Institute Inc., Cary, NC) was used for all analyses.
Description of population
The age of 7,144 participants ranged from 65 to 115 years, with an average of 87 years; 55%
of participants were female. The mean SBP, DBP, PP and MAP were 135.5, 80.1, 55.4 and
98.6 mm Hg, respectively; 42.3% of participants had hypertension (Table 1). The average
MMSE score was 21.1, and prevalence of cognitive impairment was 38.5% (27.8% for men
and 47.3% for women). The participants who were men, living in urban areas, participating in
physical activity, and with cardiovascular diseases were less likely to be cognitively
impaired. The participants with type 2 diabetes or stroke and cerebrovascular diseases were
more likely to be cognitively impaired (Table 1). The prevalence of hypertension or blood
pressure measures was not significantly different in those with and without cognitive
impairment.
Associations between blood pressure and cognitive impairment
The results of GAMs and quadratic models suggested a U-shaped association between SBP,
DBP, PP, and MAP and cognitive impairment. Logistic models were consistent with the Ushaped associations between cognitive impairment and SBP, DBP, and MAP; however, such
an association was not apparent for PP, regardless of considering PP as a continuous or
categorical variable.
SBP and cognitive impairment
Among the participants whose SBP levels were below the cut-point (141 mm Hg), there was
a trend towards significantly decreasing risk of cognitive impairment with increasing levels
of SBP; each 1mm Hg lower SBP corresponded to a 1.4% higher risk of cognitive
impairment before adjustment (OR, 1.014; 95% CI, 1.009–1.019). The risk attenuation
remained significant after adjusting for covariates in the basic and final models, which
decreased to 0.8% (OR, 1.008; 95% CI, 1.003–1.014) and 0.7% (OR, 1.007; 95% CI, 1.002–
1.013) respectively (Table 2). Participants whose SBP levels were below the cut-point were
stratified into two equal-sized groups, the univariate analysis showed that the low SBP group
had higher risk of cognitive impairment compared to medium-low SBP group (OR, 1.25;
95% CI, 1.12–1.41). The multivariate OR (95% CI) reported in the basic model was 1.15
(1.00–1.32) and in the final model was 1.18 (1.02–1.35) (Table 3).
In contrast with findings below the cut-points, the risk of cognitive impairment was greater
with each higher unit of SBP among the participants whose SBP levels were above the cutpoints. Each 1mm Hg higher SBP corresponded to a 1.2% greater risk of cognitive

impairment in the univariate and multivariate models (Table 2). Compared with medium-high
SBP group, participants with high SBP level had a 23% higher risk of cognitive impairment
in the final model (OR, 1.23; 95% CI, 1.02–1.49) (Table 3).
DBP and cognitive impairment
Similar to the relationship seen for SBP, for DBP below the cut-points of 85 mm Hg the
increased risk of cognitive impairment was also found with lower DBP, there was a 1.1%
greater risk of cognitive impairment with each 1mm Hg lower DBP after full adjustment
(OR, 1.011; 95% CI, 1.003–1.020). Compared with medium-low DBP group, participants
with low DBP levels had a 33% higher risk of cognitive impairment before adjustment (OR,
1.33; 95% CI, 1.19–1.49), and the association remained after the adjustment.
Above the cut-point of 85 mm Hg, when DBP was taken as a continuous variable, there was a
1.8% greater risk of cognitive impairment with each 1mm Hg increment of DBP before
adjustment and full adjustment (Table 2). When higher DBP was stratified into two equal
groups, participants with high DBP levels had a 24% higher risk of cognitive impairment
compared with medium-high DBP group in the final model (OR, 1.24; 95% CI, 1.02–1.52).
PP and cognitive impairment
Although we found a U-shaped association between cognitive impairment and PP in the
GAMs models (Figure 1), quadratic models and as a continuous variable in the univariate
logistic model, it was non-significant based on multivariate logistic regression (Table
2, Table 3).
MAP and cognitive impairment
As shown in GAMs and in quadratic models, the U-shaped association was confirmed in the
logistic regression model, that is, each 1 mm Hg lower MAP corresponded to a 1.1% greater
risk in cognitive impairment below the cut-points of 103 mm Hg, and each 1 mm Hg higher
MAP corresponded to a 2.1% greater risk in cognitive impairment above the cut-points of
103 mm Hg (Table 2). Poorer cognitive performance was found in those with low MAP level
compared to those with medium-low MAP level, and in those with high MAP level compared
to those with medium-high MAP level (Table 3)
Discussion
U-shaped association between blood pressure and cognitive impairment
In this cross-sectional study of 7144 Chinese elderly aged 65 years and older, we observed Ushaped associations between blood pressure (SBP, DBP, and MAP) and cognitive
impairment, with extremes of blood pressures associated with poorer cognitive performance
after controlling for demographic, lifestyle and biological confounding factors. This
association was less evident for PP as the U-shaped relationship identified in the GAMs,
quadratic models and univariate logistic models, Previous studies have provided inconsistent
results, indicating linear, J-shaped or no association [2–9]. Notably, one proposed explanation
was that linear function based on experience rather than the natural shape between blood
pressure and cognitive impairment may not adequately describe the association.
Several previous reports are consistent with our finding of a U-shaped association of blood
pressure with cognitive impairment or dementia [10–14]. In a cross-sectional study conducted
in a biracial community, the highest cognitive function scores were found in the elderly aged
65 and older whose SBP was at the mean of 140 mm Hg, or in the persons whose DBP was at

the mean of 77 mm Hg [10]. Similarly, this phenomenon was also confirmed in a 9-year
longitudinal study in which a U-shaped association with higher risk of cognitive impairment
among individuals with higher (≥160 mm Hg) and lower SBP (<130 mm Hg), as well as
higher DBP (≥80mm Hg) and lower DBP (<70mm Hg) [12]. This was somewhat consistent
for the very elderly, aged 75 and older, where SBP was significantly associated with MMSE
in a U-shaped fashion and there was also a linear relationship with PP but no association with
DBP [13]. What is distinctive in the current study is that it includes a large sample of the very
elderly, and applies GAMs and the quadratic models identify cut-points that more naturally
describe the shape of the relationship between blood pressure and cognitive impairment.
High PP in older adults is recognized as a marker of increased artery stiffness and widespread
atherosclerosis [32], and may lead to decreased perfusion of the cerebral white matter and
ultimately increase the risk for cognitive impairment as seen in some previous studies [21–
23]. A U-shaped association between PP and cognitive impairment found in a previous study
[20], was also found in GAMs, quadratic models and univariate logistic models, but not
confirmed when logistic models were further performed in our study.
It has been speculated that low or high blood pressure may be an early manifestation of the
same pathological changes that lead to cognitive impairment, that is, damage to the brain
regions that regulate blood pressure [33]. The association between blood pressure and
cognitive impairment is problematic, and may be an effect of intermediate confounding
factors affecting both blood pressure and cognitive performance such as weight loss and
dietary change [34,35], or an effect of shared risk factors such as psychological stress and
oxidative stress [36–38]. Another hypothesis is the healthy survivor bias. Probably, some
people whose blood pressure was too low or too high had died before aged 65 years due to a
window of susceptibility to related diseases (such as hemorrhagic or ischemic stroke) in
middle age, thus, the elderly in our study were a selected middle blood pressure population
whose health status was better, including a better cognitive performance.
Notably, the explanations and mechanisms of how both higher blood pressure and lower
blood pressure impairs cognitive function are likely to be different.
High blood pressure was associated with cognitive impairment
The association between hypertension and cognitive performance may be atherosclerosis,
cerebral hypoperfusion and white matter lesions [39–43]. Hypertension is a powerful risk
factor for atherosclerosis throughout the arterial tree [40], which leads to redistribution of
blood flow and further decrease in cerebral perfusion [41]. This phenomenon has been shown
to be exceedingly important for cerebral metabolism and cognition [42]. Additionally, studies
have indicated relationships between abnormalities of the white matter and hypertension [43],
and such white matter lesions are frequently associated with cognitive impairment [42].
Abnormalities of the renin angiotensin system have also been involved in the pathogenesis of
both hypertension and cognitive impairment. Also, in recent years antihypertensive drugs
have been used in the treatment and prevention of Alzheimer’s disease via the reninangiotensin system [44]. It is also hypothesized that hypoperfusion-hypoxia might accelerate
cognitive impairment through inducing expression of vasoactive mediators such as nitric
oxide, hypoxia-inducible-factor-1 , and vascular endothelial growth factor [45].
Low blood pressure was associated with cognitive impairment
For obvious reasons, low blood pressure can cause cerebral hypoperfusion [46]. It had also
been argued that decline in blood pressure may reduce the velocity of cerebral blood flow,

which can further cause damage to neural tissue and add to the pathological mechanisms of
cognitive impairment. Reduced cerebral blood flow has been found both in individuals with
dementia and in those showing early signs of dementia [46, 47]. Furthermore, it has been
proposed that severe atherosclerosis resulting from long-standing low blood pressure in
midlife and later-life may lead to cerebral hypoperfusion, which may be two biological
pathways [48]. The review by Duschek and colleagues suggested the mechanisms of
hypotension for reducing cognitive performance include diminished cortical activity,
deficient regulation of cerebral blood flow in persons with low blood pressure, and
insufficient adjustment of blood flow to cognitive requirements [49]. However, most studies
focus on possible mechanisms of cognitive impairment caused by low blood pressure; we
haven’t found related researches on the mechanism of lower blood pressure within the
normotensive range.
Limitations
Our study has several limitations. First, it is not possible to assess the direction of the
association since both exposure and outcome are assessed simultaneously. Second, the blood
pressure measurement took place at a single visit and missing data on use of antihypertensive
medications may diminish the data accuracy. Third, our findings may not be applicable to
younger populations because CLHLS over-sampled the oldest-old and dynamics of blood
pressure changes with age. Finally, weight loss and dietary change, psychological stress and
an oxidative stress may be confounding factors, but they were not measured and controlled in
this study.
Conclusions
Our results suggest a U-shaped association between blood pressure (including SBP, DBP,
MAP) and cognitive functions, that is, both higher and lower levels of blood pressure were
associated with higher risk of cognitive impairment, which may have several implications for
clinical practice and cognitive impairment prevention. First, both lower and higher blood
pressure may be used to identify the high-risk population for cognitive impairment.
Furthermore, it may point to the need to individualize blood pressure management for
cognitive impairment prevention, that is, we should not only address blood pressure-lowering
therapy in elderly with hypertension, but may also focus on raising blood pressure in elderly
with relatively lower blood pressure. Future prospective longitudinal studies with blood
pressure monitoring and extensive cognitive testing are needed to confirm the association we
found in this study.
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Table 1
Characteristics of 7,144 Chinese elderly by cognitive status, 2011

Factors

Normal
cognition
n=4393

Cognitive
impairment
n=2751

Total
n=7144

P-value

MMSE

26.8(2.3)

9.2(6.7)

21.1(10.9)

<0.0001

Age (year)

83.3(9.7)

93.2(9.7)

87.1(10.9)

<0.0001

2335(46.9)

900(32.7)

3235(45.3)

<0.0001

2058(53.1)

1851(67.3)

3909(54.7)

Urban

2226(59.8)

1464(53.2)

4430(57.2)

Rural

1787(40.2)

1287(46.8)

3054(42.8)

Education (year)

3.2(3.0)

1.1(2.5)

2.4(3.6)

<0.0001

Physically active

2100(48.0)

671(24.5)

2771(39.0)

<0.0001

Good visual function

3749(85.3)

1577(57.3)

5326(74.6)

<0.0001

Central obesity

2198(50.0)

1102(40.1)

3300(46.2)

<0.0001

Diabetes mellitus

248(5.9)

92(3.7)

340(5.1)

<0.0001

Cardiovascular diseases

653(15.5)

324(12.8)

977(14.5)

0.0024

Stroke and cerebrovascular
diseases

332(7.9)

265(10.4)

597(8.8)

0.0004

Systolic blood pressure
(mmHg)

135.7(19.4)

135.2(22.0)

135.5(20.4) 0.3055

Diastolic blood pressure
(mmHg)

80.3(11.2)

79.8(12.9)

80.1(11.9)

0.1302

Pulse pressure (mmHg)

55.4(15.9)

55.4(17.5)

55.4(16.6)

0.8600

Mean arterial
pressure(mmHg)

98.8(12.3)

98.3(14.3)

98.6(13.1)

0.1494

*

Gender
Male
Female
Residence
<0.0001

Hypertension
1859(42.3)
1162(42.2)
3021(42.3) 0.9481
Dichotomous variables listed as n (%), including gender, current smoking practice, alcohol
drinking habits, central obesity, diabetes, cardiovascular diseases, stroke and cerebrovascular
diseases, hypertension, were compared between two cognitive status groups using Chi-square
tests; Continuous variables listed as mean (standard deviation), including age, education,
SBP, DBP, PP, MAP, were comparted between two groups using Student’s T tests or
Cochran-Cox tests. MMSE, Mini Mental State Examination.

*

Table 2
Logistic odds ratio (95% Confidence Intervals) for cognitive impairment and continuous
measures of blood pressure among Chinese elderly.
Variables

Unadjusted

Basic model‡

Final model§

Each 1mmHg lower in
participants with SBP
<141mmHg (n=4733)

1.014(1.009–
1.019) †

1.008(1.003–
1.014) †

1.007(1.002–
1.013) †

Each 1mmHg higher in
participants with SBP
≥141mmHg ( n=2411)

1.012(1.006–
1.017) †

1.010(1.004–
1.017) †

1.012(1.005–
1.019) †

Each 1mmHg lowerin
participants with
DBP<85mmHg (n=5180)

1.023(1.015–
1.030) †

1.011(1.003–
1.019) †

1.011(1.003–
1.020)*

Each 1mmHg higherin
participants with DBP
≥85mmHg (n=1964)

1.018(1.007–
1.028) †

1.021(1.009–
1.033) †

1.018(1.006–
1.030) †

Each 1mmHg lower in
participants with
PP<62mmHg (n=5111)

1.013(1.007–
1.20) †

1.008(1.001–
1.015)*

1.008(1.000–
1.015)*

Each 1mmHg higherin
participants with
PP≥62mmHg (n=2033)

1.009(1.002–
1.017)*

1.002(0.994–
1.011)

1.005(0.996–
1.013)

Each 1mmHg lower in
participants with
MAP<103mmHg (n=4792)

1.022(1.014–
1.029) †

1.012(1.004–
1.021) †

1.011(1.003–
1.020)*

Each 1mmHg higher in
participants with
MAP≥103mmHg (n=2352)

1.021(1.012–
1.030) †

1.022(1.012–
1.033) †

1.021(1.011–
1.032) †

*

p<0.05

†

p<0.01.

‡

Adjusted for demographic variables including age (year), gender, education level (year),
residence in basic model,
§

Further adjusted physical activity, vision, waist circumference, type 2 diabetes mellitus,
cardiovascular diseases and stroke and cerebrovascular diseases in final model.

DBP diastolic blood pressure; MAP mean arterial pressure, PP pulse pressure, SBP systolic
blood pressure.

Table 3
Logistic odds ratio (95 % confidence intervals) for cognitive impairment and blood pressure
categories among Chinese elderly. †
Unadjusted

Basic model‡

Final model§

1.25(1.12–
1.41)†

1.15(1.00–
1.32)*

1.18(1.02–
1.35)*

Medium-low (127≤ SBP<141mmHg,
n=2409)

1.00 reference

1.00 reference

1.00 reference

Medium-high (141≤ SBP<155mmHg,
n=1284)

1.00 reference

1.00 reference

1.00 reference

1.21(1.02–
1.42)*

1.18(0.99–
1.42)

1.23(1.02–
1.49)*

1.33(1.19–
1.49)†

1.20(1.05–
1.36)†

1.20(1.05–
1.37)†

Medium-low (77≤ DBP<85mmHg,
n=2644)

1.00 reference

1.00 reference

1.00 reference

Medium-High (85≤ DBP<90mmHg,
n=989)

1.00 reference

1.00 reference

1.00 reference

1.26(1.07–
1.50)†

1.26(1.04–
1.52)*

1.24(1.02–
1.52)*

1.18(1.05–
1.32)†

1.08(0.95–
1.23)

1.09(0.95–
1.25)

Medium-low (49≤ PP<62mmHg,
n=2588)

1.00 reference

1.00 reference

1.00 reference

Medium-high (62≤ PP<73mmHg,
n=1035)

1.00 reference

1.00 reference

1.00 reference

1.04(0.87–
1.24)

0.90(0.74–
1.10)

1.04(0.84–
1.28)

Variables
SBP
Low(SBP<127mmHg, n=2324)

High(SBP≥155mmHg, n=1127)

DBP
Low(DBP<77mmHg, n=2536)

High(DBP≥90mmHg, n=975)

PP
Low(PP<49mmHg, n=2523)

High (PP≥73mmHg, n=998)

Unadjusted

Basic model‡

Final model§

1.31(1.17–
1.48)†

1.15(1.00–
1.33)

1.15(1.00–
1.34)*

Medium-low (93≤ MAP<103mmHg,
n=2232)

1.00 reference

1.00 reference

1.00 reference

Medium-high (103≤ MAP<110mmHg,
n=1 186)

1.00 reference

1.00 reference

1.00 reference

1.21(0.99–
1.33)

1.20(0.99–
1.44)

1.22(1.01–
1.48)*

Variables
MAP
Low(MAP<93mmHg, n=2560)

High (MAP≥1 10mmHg, n=1 166 )
*

p<0.05

†

p<0.01.

‡

Adjusted for demographic variables including age (year), gender, education level (year),
residence in basic model, §Further adjusted physical activity, vision, waist circumference,
type 2 diabetes mellitus, cardiovascular diseases and stroke and cerebrovascular diseases in
final model.
DBP diastolic blood pressure; MAP mean arterial pressure, PP pulse pressure, SBP systolic
blood pressure.

Figure 1
Smoothing component for cognitive impairment
Legends: Associations of SBP, DBP, PP and MAP with cognitive impairment for the elderly,
Chinese Longitudinal Healthy Longevity Survey, China, 2011. The lines depict the estimated
function of SBP, DBP, PP and MAP respectively, for risk of cognitive impairment among the
elderly, and the shaded area indicates the 95% confidence intervals.
SBP, Systolic blood pressure; DBP, diastolic blood pressures; PP, pulse pressure; MAP,
mean arterial pressure.

